NASDAQ:RPRX
Royalty Pharma plc Stock News
$26.62
-0.230 (-0.86%)
At Close: May 24, 2024
Royalty Pharma Declares Fourth-Quarter 2021 Dividend
09:00am, Friday, 15'th Oct 2021
NEW YORK, Oct. 15, 2021 (GLOBE NEWSWIRE) -- The board of directors of Royalty Pharma plc (Nasdaq: RPRX) has approved the payment of a dividend for the fourth quarter of 2021 of $0.17 per Class A ordin
Top 3 undervalued US biotech stocks to buy
02:27pm, Tuesday, 12'th Oct 2021
With the US Q3 earnings season just getting started, there are a few biotech stocks that present an exciting opportunity for value investors. Some of these stocks look significantly undervalued after
Royalty Pharma to Present at Upcoming Investor Conferences
09:00am, Friday, 03'rd Sep 2021
NEW YORK, Sept. 03, 2021 (GLOBE NEWSWIRE) -- Royalty Pharma plc (Nasdaq: RPRX) today announced that it will participate in the following upcoming investor conferences during the month of September:
Wall Street Journal Creates A Pitch In Favor Of Royalty Pharma
01:50pm, Tuesday, 17'th Aug 2021
Drug development, both a lucrative and a risky segment. Royalty Pharma plc (NASDAQ: RPRX) offers a middle ground for its investors.
Royalty Pharma's (RPRX) CEO Pablo Legorreta on Q2 2021 Results - Earnings Call Transcript
01:30pm, Wednesday, 11'th Aug 2021
Royalty Pharma's (RPRX) CEO Pablo Legorreta on Q2 2021 Results - Earnings Call Transcript
Royalty Pharma (RPRX) Q2 Earnings and Revenues Surpass Estimates
11:00am, Wednesday, 11'th Aug 2021
Royalty Pharma (RPRX) delivered earnings and revenue surprises of 1.43% and 0.10%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock?
Recap: Royalty Pharma Q2 Earnings
07:38am, Wednesday, 11'th Aug 2021
Shares of Royalty Pharma (NASDAQ:RPRX) rose 3.8% in pre-market trading after the company reported Q2 results. Quarterly Results Earnings per share were down 26.26% year over year to $0.73, which beat
Royalty Pharma Reports Second Quarter 2021 Results
07:00am, Wednesday, 11'th Aug 2021
NEW YORK, Aug. 11, 2021 (GLOBE NEWSWIRE) -- Royalty Pharma plc (Nasdaq: RPRX) today reported financial results for the second quarter of 2021 and raised full-year 2021 guidance for Adjusted Cash Recei
Royalty Pharma Declares Third-Quarter 2021 Dividend
09:00am, Friday, 16'th Jul 2021
NEW YORK, July 16, 2021 (GLOBE NEWSWIRE) -- The board of directors of Royalty Pharma plc (Nasdaq: RPRX) has approved the payment of a dividend for the third quarter of 2021 of $0.17 per class A ordina
Royalty Pharma Announces Pricing of $1.3 Billion of Senior Unsecured Notes, Including $600 Million Social Bond
04:54pm, Thursday, 15'th Jul 2021
NEW YORK, July 15, 2021 (GLOBE NEWSWIRE) -- Royalty Pharma plc (Nasdaq: RPRX) announced today that it has priced an offering of $1.3 billion of senior unsecured notes, comprised of the following (col
Royalty Pharma Insights: Return On Capital Employed
09:53am, Wednesday, 02'nd Jun 2021
Royalty Pharma (NASDAQ:RPRX) posted a 26.99% decrease in earnings from Q4. Sales, however, increased by 0.18% over the previous quarter to $573.03 million.
MorphoSys to Acquire Constellation Pharma at $34/Share; Enters $2B Strategic Funding with Royalty Pharma
09:10am, Wednesday, 02'nd Jun 2021
MorphoSys AG (NASDAQ: MOR) has agreed to acquire Constellation Pharmaceuticals Inc (NASDAQ: CNST) for $34/share in cash, representing a total equity value of $1.7 billion. The transaction is expec
Royalty Pharma Announces $2.025 Billion Strategic Funding Partnership With MorphoSys
07:40am, Wednesday, 02'nd Jun 2021
NEW YORK and PLANEGG, Germany, June 02, 2021 (GLOBE NEWSWIRE) -- Royalty Pharma plc (Nasdaq: RPRX) and MorphoSys AG (FSE: MOR; Nasdaq: MOR) today announced a $2.025 billion strategic funding partnersh
Royalty Pharma plc (RPRX) CEO Pablo Legorreta on Q1 2021 Results - Earnings Call Transcript
01:29pm, Tuesday, 11'th May 2021
Royalty Pharma plc (RPRX) CEO Pablo Legorreta on Q1 2021 Results - Earnings Call Transcript
Royalty Pharma to Announce First-Quarter 2021 Financial Results on May 11, 2021
04:15pm, Wednesday, 21'st Apr 2021
NEW YORK, April 21, 2021 (GLOBE NEWSWIRE) -- Royalty Pharma plc (Nasdaq: RPRX) today announced that it will report its first quarter 2021 financial results on Tuesday, May 11, 2021 before the U.S. fin